Contrast agent developer Epix Medical has signed an agreement with investment banking firm Robertson Stephens, which will serve as a placement agent for newly issued Epix shares. Robertson Stephens has received commitments from a group of existing and new Epix investors for 2.6 million shares at a price of $12.50 a share, resulting in net proceeds of approximately $30.2 million, according to Cambridge, MA-based Epix.
By AuntMinnie.com staff writersJanuary 16, 2002
Related Reading
Epix revenues climb in Q3, October 19, 2001
Epix, Bracco ink licensing deal, September 25, 2001
Wirth joins Epix Medical board, August 30, 2001
Epix net loss grows in Q2, July 27, 2001
Epix trims net loss, April 27, 2001
Copyright © 2002 AuntMinnie.com
